beclomethasone dipropionate · Norton Waterford · NDA 207921
Qvar Redihaler
Earliest generic entry, as listed · earliest of 2 marketed strengths
19 Aug 2041
Blocked by patent: US 11583643.
Listed patents · 8 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 11583643 | drug product · sets the listed date | 19 Aug 2041 |
| US 11957832 | drug product | 5 May 2041 |
| US 11559637 | drug product | 21 Jul 2039 |
| US 10792447 | drug product | 25 Jan 2039 |
| US 11395888 | drug product | 26 Jan 2038 |
| US 11793953 | drug product | 26 Jan 2038 |
| US 12296089 | drug product | 26 Jan 2038 |
| US 8931476 | drug product | 17 Jul 2031 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 2
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 207921 · 001 · RLD | aerosol, metered, inhalation | 0.04MG/INH | 19 Aug 2041 |
| 207921 · 002 · RLD | aerosol, metered, inhalation | 0.08MG/INH | 19 Aug 2041 |
Expired or delisted (9)
- US 11865247 · product · 26 Jan 2038 · delisted
- US 11896759 · product · 26 Jan 2038 · delisted
- US 10561808 · product · 1 Jan 2032 · delisted
- US 10022509 · product · 18 May 2031 · delisted
- US 10022510 · product · 18 May 2031 · delisted
- US 10086156 · product · 18 May 2031 · delisted
- US 10695512 · product · 18 May 2031 · delisted
- US 11395889 · product · 18 May 2031 · delisted
- US 8132712 · product · 7 Sep 2028 · delisted